Metabolomic Analysis of Vitamin E Supplement Use in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Overview

Journal Nutrients

Date 2023 Jul 14

PMID 37447163

Authors

Jungeun Lim

Hyokyoung G Hong

Stephanie J Weinstein

Mary C Playdon

Amanda J Cross

Rachael Stolzenberg-Solomon

Neal D Freedman

Jiaqi Huang

Demetrius Albanes

Affiliations

Soon will be listed here.

Abstract

The effects of vitamin E supplementation on cancer and other chronic diseases are not clear. We compared the serum metabolomic profile of differing vitamin E dosages in order to re-examine the previously observed changes in a novel C lactone sulfate compound, androgenic steroids, and other metabolites. A total of 3409 women and men previously selected for metabolomics studies in the PLCO Cancer Screening Trial were included in this investigation. Serum metabolites were profiled using ultrahigh-performance liquid and gas chromatography/tandem mass spectrometry. Seventy known metabolites including C lactone sulfate and androgens were significantly associated with vitamin E supplementation. In the sex-stratified analysis, 10 cofactors and vitamins (e.g., alpha-CEHC sulfate and alpha-CEHC glucuronide), two carbohydrates (glyceric and oxalic acids), and one lipid (glycocholenate sulfate) were significantly associated with vitamin E dose in both males and females (FDR-adjusted -value < 0.01). However, the inverse association between C lactone sulfate and daily vitamin E supplementation was evident in females only, as were two androgenic steroids, 5-androstenediol and androsterone glucuronide. Our study provides evidence of distinct steroid hormone pathway responses based on vitamin E dosages. Further studies are needed to gain biological insights into vitamin E biochemical effects relevant to cancer and other chronic diseases.

References

Huang J, Hodis H, Weinstein S, Mack W, Sampson J, Mondul A . Serum Metabolomic Response to Low- and High-Dose Vitamin E Supplementation in Two Randomized Controlled Trials. Cancer Epidemiol Biomarkers Prev. 2020; 29(7):1329-1334. PMC: 7340214. DOI: 10.1158/1055-9965.EPI-20-0187. View

Li Y, Zhang L, Jia M, Hu X . CYP3AP1*3 allele is associated with lipid-lowering efficacy of simvastatin and atorvastatin in Chinese women. J Clin Pharmacol. 2010; 51(2):181-8. DOI: 10.1177/0091270010370589. View

Meydani S, Beharka A . Recent developments in vitamin E and immune response. Nutr Rev. 1998; 56(1 Pt 2):S49-58. DOI: 10.1111/j.1753-4887.1998.tb01644.x. View

Shklar G, Schwartz J . Vitamin E inhibits experimental carcinogenesis and tumour angiogenesis. Eur J Cancer B Oral Oncol. 1996; 32B(2):114-9. DOI: 10.1016/0964-1955(95)00077-1. View

Cui L, Li L, Tian Y, Xu F, Qiao T . Association between Dietary Vitamin E Intake and Esophageal Cancer Risk: An Updated Meta-Analysis. Nutrients. 2018; 10(7). PMC: 6073499. DOI: 10.3390/nu10070801. View

Traber M, Sies H . Vitamin E in humans: demand and delivery. Annu Rev Nutr. 1996; 16:321-47. DOI: 10.1146/annurev.nu.16.070196.001541. View

de Sousa Coelho M, Pereira I, Feitosa de Oliveira K, Oliveira I, Dos Santos Rizzo M, de Oliveira V . Chemopreventive and anti-tumor potential of vitamin E in preclinical breast cancer studies: A systematic review. Clin Nutr ESPEN. 2023; 53:60-73. DOI: 10.1016/j.clnesp.2022.11.001. View

Huang J, Mondul A, Weinstein S, Koutros S, Derkach A, Karoly E . Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Br J Cancer. 2016; 115(9):1087-1095. PMC: 5117796. DOI: 10.1038/bjc.2016.305. View

Kawasaki B, Hurt E, Kalathur M, Duhagon M, Milner J, Kim Y . Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach. Prostate. 2009; 69(8):827-37. PMC: 2700306. DOI: 10.1002/pros.20931. View

10.

Prorok P, Andriole G, Bresalier R, Buys S, Chia D, Crawford E . Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2001; 21(6 Suppl):273S-309S. DOI: 10.1016/s0197-2456(00)00098-2. View

11.

Lin J, Chen S, Liu H, Yan Y, Zheng J . Vitamin E consumption and the risk of bladder cancer. Int J Vitam Nutr Res. 2019; 89(3-4):168-175. DOI: 10.1024/0300-9831/a000553. View

12.

Samandari E, Visarius T, Zingg J, Azzi A . The effect of gamma-tocopherol on proliferation, integrin expression, adhesion, and migration of human glioma cells. Biochem Biophys Res Commun. 2006; 342(4):1329-33. DOI: 10.1016/j.bbrc.2006.02.110. View

13.

Sigounas G, Anagnostou A, Steiner M . dl-alpha-tocopherol induces apoptosis in erythroleukemia, prostate, and breast cancer cells. Nutr Cancer. 1997; 28(1):30-5. DOI: 10.1080/01635589709514549. View

14.

Zhang Y, Ni J, Messing E, Chang E, Yang C, Yeh S . Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci U S A. 2002; 99(11):7408-13. PMC: 124244. DOI: 10.1073/pnas.102014399. View

15.

Gaziano J, Glynn R, Christen W, Kurth T, Belanger C, MacFadyen J . Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008; 301(1):52-62. PMC: 2774210. DOI: 10.1001/jama.2008.862. View

16.

Playdon M, Ziegler R, Sampson J, Stolzenberg-Solomon R, Thompson H, Irwin M . Nutritional metabolomics and breast cancer risk in a prospective study. Am J Clin Nutr. 2017; 106(2):637-649. PMC: 5525118. DOI: 10.3945/ajcn.116.150912. View

17.

Pondugula S, Pavek P, Mani S . Pregnane X Receptor and Cancer: Context-Specificity is Key. Nucl Receptor Res. 2016; 3. PMC: 5017004. DOI: 10.11131/2016/101198. View

18.

Fredericks W, Sepulveda J, Lai P, Tomaszewski J, Lin M, McGarvey T . The tumor suppressor TERE1 (UBIAD1) prenyltransferase regulates the elevated cholesterol phenotype in castration resistant prostate cancer by controlling a program of ligand dependent SXR target genes. Oncotarget. 2013; 4(7):1075-92. PMC: 3759667. DOI: 10.18632/oncotarget.1103. View

19.

Yang H, Jia X, Chen X, Yang C, Li N . Time-selective chemoprevention of vitamin E and selenium on esophageal carcinogenesis in rats: the possible role of nuclear factor kappaB signaling pathway. Int J Cancer. 2012; 131(7):1517-27. DOI: 10.1002/ijc.27423. View

20.

Evans A, Dehaven C, Barrett T, Mitchell M, Milgram E . Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem. 2009; 81(16):6656-67. DOI: 10.1021/ac901536h. View